Total Payments
$3,015
2024 Payments
$67.98
Companies
17
Transactions
92
Medicare Patients
261
Medicare Billing
$29,444
Payment Breakdown by Category
Food & Beverage$2,876 (95.4%)
Education$84.49 (2.8%)
Travel$48.25 (1.6%)
Consulting$6.01 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,876 | 88 | 95.4% |
| Education | $84.49 | 1 | 2.8% |
| Travel and Lodging | $48.25 | 2 | 1.6% |
| Consulting Fee | $6.01 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $741.73 | 24 | $0 (2022) |
| ABIOMED | $618.17 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $453.77 | 13 | $0 (2023) |
| Abbott Laboratories | $406.03 | 8 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $384.02 | 11 | $0 (2022) |
| Boston Scientific Corporation | $88.79 | 3 | $0 (2023) |
| Kestra Medical Technology Services, Inc. | $58.86 | 2 | $0 (2024) |
| PFIZER INC. | $52.27 | 3 | $0 (2021) |
| Medtronic Vascular, Inc. | $44.95 | 3 | $0 (2018) |
| ShockWave Medical, Inc | $30.84 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67.98 | 2 | Kestra Medical Technology Services, Inc. ($35.80) |
| 2023 | $159.41 | 6 | ABIOMED ($53.89) |
| 2022 | $130.24 | 6 | Boston Scientific Corporation ($51.76) |
| 2021 | $349.85 | 7 | Janssen Pharmaceuticals, Inc ($172.58) |
| 2020 | $434.33 | 15 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($234.64) |
| 2019 | $673.81 | 23 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($234.19) |
| 2018 | $442.70 | 19 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($249.44) |
| 2017 | $756.86 | 14 | Abbott Laboratories ($364.36) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $32.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/02/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $35.80 | General |
| Category: Cardiology | ||||||
| 10/20/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/13/2023 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Transcatheter Valve Systems | ||||||
| 09/09/2023 | Boston Scientific Corporation | ROTAPRO (Device) | Food and Beverage | In-kind items and services | $37.03 | General |
| Category: ROTAPRO_IC | ||||||
| 06/30/2023 | ShockWave Medical, Inc | SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) | Food and Beverage | In-kind items and services | $30.84 | General |
| Category: Lithoplasty | ||||||
| 04/22/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2022 | Boston Scientific Corporation | RotaWire and wireClip Torquer (Device) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: RotaWire_IC | ||||||
| 08/16/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.21 | General |
| Category: Cardiovascular | ||||||
| 07/22/2022 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $23.06 | General |
| Category: Cardiology | ||||||
| 06/30/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/29/2022 | Boston Scientific Corporation | ROTAPRO (Device) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: ROTAPRO_IC | ||||||
| 02/02/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/17/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/18/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/18/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/11/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/08/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/20/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $94.99 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/30/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/22/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 55 | 66 | $24,346 | $5,251 |
| 2022 | 4 | 64 | 74 | $25,934 | $6,791 |
| 2021 | 5 | 84 | 126 | $38,793 | $10,649 |
| 2020 | 4 | 58 | 73 | $31,449 | $6,753 |
Total Patients
261
Total Services
339
Medicare Billing
$29,444
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 13 | 13 | $16,653 | $3,667 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 16 | $4,192 | $1,257 | 30.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 15 | 15 | $2,775 | $180.60 | 6.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 15 | 22 | $726.00 | $146.20 | 20.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $11,951 | $3,192 | 26.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 22 | $7,942 | $2,125 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 14 | $5,348 | $1,335 | 25.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 19 | 21 | $693.00 | $139.36 | 20.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 17 | 17 | $11,951 | $3,261 | 27.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 25 | $9,550 | $2,827 | 29.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 27 | $9,747 | $2,665 | 27.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 24 | $6,456 | $1,651 | 25.6% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 20 | 33 | $1,089 | $245.21 | 22.5% |
| 93458 | Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart | Facility | 2020 | 11 | 11 | $14,091 | $2,943 | 20.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 19 | 22 | $7,942 | $1,994 | 25.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 24 | $6,456 | $1,625 | 25.2% |
| 99152 | Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | Facility | 2020 | 16 | 16 | $2,960 | $190.32 | 6.4% |
About Dr. Erdal Cavusoglu, M.D
Dr. Erdal Cavusoglu, M.D is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417941683.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erdal Cavusoglu, M.D has received a total of $3,015 in payments from pharmaceutical and medical device companies, with $67.98 received in 2024. These payments were reported across 92 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,876).
As a Medicare-enrolled provider, Cavusoglu has provided services to 261 Medicare beneficiaries, totaling 339 services with total Medicare billing of $29,444. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Brooklyn, NY
- Active Since 09/02/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1417941683
Products in Payments
- LifeVest (Device) $741.73
- Impella (Device) $618.17
- XARELTO (Drug) $384.02
- LOKELMA (Drug) $269.94
- Xience V coronary stent system (Device) $248.80
- BRILINTA (Drug) $115.19
- Xience Alpine cornary stent system (Device) $107.57
- ROTAPRO (Device) $69.13
- ELIQUIS (Drug) $63.71
- Assure WCD (Device) $58.86
- Resolute (Device) $44.95
- Perclose ProGlide suture mediated closure system (Device) $41.67
- FARXIGA (Drug) $39.34
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $30.84
- ReDS system (Device) $25.60
- IGT D Coronary (Device) $23.66
- COREVALVE EVOLUT R (Device) $20.42
- KENGREAL (Drug) $20.00
- RotaWire and wireClip Torquer (Device) $19.66
- LEXISCAN (Drug) $14.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Cardiovascular Disease $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Cardiovascular Disease $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Cardiovascular Disease $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Cardiovascular Disease $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Cardiovascular Disease $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799
Cardiovascular Disease $225,799